Pharma & Healthcare
Global Therapeutic Peptide APIs Market Research Report 2026
- Mar 17, 26
- ID: 743464
- Pages: 140
- Figures: 142
- Views: 3
This report delivers a comprehensive overview of the global Therapeutic Peptide APIs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Therapeutic Peptide APIs. The Therapeutic Peptide APIs market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Therapeutic Peptide APIs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Therapeutic Peptide APIs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Bachem
GenScript
AmbioPharm
Limitless Biotech
CPC Scientific
PolyPeptide
CordenPharma
Lonza
Aspen API
Syngene
USV Peptides
Bio Basic
JPT Peptide Technologies
ScinoPharm
Piramal Pharma
Jiangsu Sinopep-Allsino Biopharmaceutical
Cheng Du Sheng Nuo Biotec
Hybio Pharmaceutical
Hainan Shuangcheng Pharmaceuticals
Guangdong Jianyuan Pharmaceutical
Zhejiang Peptites Biotech
Segment by Type
Bioactive Peptides
Synthetic Peptides
by Application
Pharmaceuticals
Scientific Research
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Therapeutic Peptide APIs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Therapeutic Peptide APIs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Therapeutic Peptide APIs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Therapeutic Peptide APIs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Bachem
GenScript
AmbioPharm
Limitless Biotech
CPC Scientific
PolyPeptide
CordenPharma
Lonza
Aspen API
Syngene
USV Peptides
Bio Basic
JPT Peptide Technologies
ScinoPharm
Piramal Pharma
Jiangsu Sinopep-Allsino Biopharmaceutical
Cheng Du Sheng Nuo Biotec
Hybio Pharmaceutical
Hainan Shuangcheng Pharmaceuticals
Guangdong Jianyuan Pharmaceutical
Zhejiang Peptites Biotech
Segment by Type
Bioactive Peptides
Synthetic Peptides
by Application
Pharmaceuticals
Scientific Research
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Therapeutic Peptide APIs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Therapeutic Peptide APIs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Therapeutic Peptide APIs Market Overview
1.1 Product Definition
1.2 Therapeutic Peptide APIs by Type
1.2.1 Global Therapeutic Peptide APIs Market Value by Type: 2025 vs 2032
1.2.2 Bioactive Peptides
1.2.3 Synthetic Peptides
1.3 Therapeutic Peptide APIs by Application
1.3.1 Global Therapeutic Peptide APIs Market Value by Application: 2025 vs 2032
1.3.2 Pharmaceuticals
1.3.3 Scientific Research
1.3.4 Other
1.4 Global Therapeutic Peptide APIs Market Size Estimates and Forecasts
1.4.1 Global Therapeutic Peptide APIs Revenue 2021–2032
1.4.2 Global Therapeutic Peptide APIs Sales 2021–2032
1.4.3 Global Therapeutic Peptide APIs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Therapeutic Peptide APIs Market Competition by Manufacturers
2.1 Global Therapeutic Peptide APIs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Therapeutic Peptide APIs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Therapeutic Peptide APIs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Therapeutic Peptide APIs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Therapeutic Peptide APIs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Therapeutic Peptide APIs, Product Types and Applications
2.7 Global Key Manufacturers of Therapeutic Peptide APIs, Date of Entry into the Industry
2.8 Global Therapeutic Peptide APIs Market Competitive Situation and Trends
2.8.1 Global Therapeutic Peptide APIs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Therapeutic Peptide APIs Players Market Share by Revenue
2.8.3 Global Therapeutic Peptide APIs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Therapeutic Peptide APIs Market Scenario by Region
3.1 Global Therapeutic Peptide APIs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Therapeutic Peptide APIs Sales by Region: 2021–2032
3.2.1 Global Therapeutic Peptide APIs Sales by Region: 2021–2026
3.2.2 Global Therapeutic Peptide APIs Sales by Region: 2027–2032
3.3 Global Therapeutic Peptide APIs Revenue by Region: 2021–2032
3.3.1 Global Therapeutic Peptide APIs Revenue by Region: 2021–2026
3.3.2 Global Therapeutic Peptide APIs Revenue by Region: 2027–2032
3.4 North America Therapeutic Peptide APIs Market Facts & Figures by Country
3.4.1 North America Therapeutic Peptide APIs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Therapeutic Peptide APIs Sales by Country (2021–2032)
3.4.3 North America Therapeutic Peptide APIs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Therapeutic Peptide APIs Market Facts & Figures by Country
3.5.1 Europe Therapeutic Peptide APIs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Therapeutic Peptide APIs Sales by Country (2021–2032)
3.5.3 Europe Therapeutic Peptide APIs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Therapeutic Peptide APIs Market Facts & Figures by Region
3.6.1 Asia Pacific Therapeutic Peptide APIs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Therapeutic Peptide APIs Sales by Region (2021–2032)
3.6.3 Asia Pacific Therapeutic Peptide APIs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Therapeutic Peptide APIs Market Facts & Figures by Country
3.7.1 Latin America Therapeutic Peptide APIs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Therapeutic Peptide APIs Sales by Country (2021–2032)
3.7.3 Latin America Therapeutic Peptide APIs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Therapeutic Peptide APIs Market Facts & Figures by Country
3.8.1 Middle East and Africa Therapeutic Peptide APIs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Therapeutic Peptide APIs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Therapeutic Peptide APIs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Therapeutic Peptide APIs Sales by Type (2021–2032)
4.1.1 Global Therapeutic Peptide APIs Sales by Type (2021–2026)
4.1.2 Global Therapeutic Peptide APIs Sales by Type (2027–2032)
4.1.3 Global Therapeutic Peptide APIs Sales Market Share by Type (2021–2032)
4.2 Global Therapeutic Peptide APIs Revenue by Type (2021–2032)
4.2.1 Global Therapeutic Peptide APIs Revenue by Type (2021–2026)
4.2.2 Global Therapeutic Peptide APIs Revenue by Type (2027–2032)
4.2.3 Global Therapeutic Peptide APIs Revenue Market Share by Type (2021–2032)
4.3 Global Therapeutic Peptide APIs Price by Type (2021–2032)
5 Segment by Application
5.1 Global Therapeutic Peptide APIs Sales by Application (2021–2032)
5.1.1 Global Therapeutic Peptide APIs Sales by Application (2021–2026)
5.1.2 Global Therapeutic Peptide APIs Sales by Application (2027–2032)
5.1.3 Global Therapeutic Peptide APIs Sales Market Share by Application (2021–2032)
5.2 Global Therapeutic Peptide APIs Revenue by Application (2021–2032)
5.2.1 Global Therapeutic Peptide APIs Revenue by Application (2021–2026)
5.2.2 Global Therapeutic Peptide APIs Revenue by Application (2027–2032)
5.2.3 Global Therapeutic Peptide APIs Revenue Market Share by Application (2021–2032)
5.3 Global Therapeutic Peptide APIs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Bachem
6.1.1 Bachem Company Information
6.1.2 Bachem Description and Business Overview
6.1.3 Bachem Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Bachem Therapeutic Peptide APIs Product Portfolio
6.1.5 Bachem Recent Developments/Updates
6.2 GenScript
6.2.1 GenScript Company Information
6.2.2 GenScript Description and Business Overview
6.2.3 GenScript Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 GenScript Therapeutic Peptide APIs Product Portfolio
6.2.5 GenScript Recent Developments/Updates
6.3 AmbioPharm
6.3.1 AmbioPharm Company Information
6.3.2 AmbioPharm Description and Business Overview
6.3.3 AmbioPharm Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 AmbioPharm Therapeutic Peptide APIs Product Portfolio
6.3.5 AmbioPharm Recent Developments/Updates
6.4 Limitless Biotech
6.4.1 Limitless Biotech Company Information
6.4.2 Limitless Biotech Description and Business Overview
6.4.3 Limitless Biotech Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Limitless Biotech Therapeutic Peptide APIs Product Portfolio
6.4.5 Limitless Biotech Recent Developments/Updates
6.5 CPC Scientific
6.5.1 CPC Scientific Company Information
6.5.2 CPC Scientific Description and Business Overview
6.5.3 CPC Scientific Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 CPC Scientific Therapeutic Peptide APIs Product Portfolio
6.5.5 CPC Scientific Recent Developments/Updates
6.6 PolyPeptide
6.6.1 PolyPeptide Company Information
6.6.2 PolyPeptide Description and Business Overview
6.6.3 PolyPeptide Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 PolyPeptide Therapeutic Peptide APIs Product Portfolio
6.6.5 PolyPeptide Recent Developments/Updates
6.7 CordenPharma
6.7.1 CordenPharma Company Information
6.7.2 CordenPharma Description and Business Overview
6.7.3 CordenPharma Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 CordenPharma Therapeutic Peptide APIs Product Portfolio
6.7.5 CordenPharma Recent Developments/Updates
6.8 Lonza
6.8.1 Lonza Company Information
6.8.2 Lonza Description and Business Overview
6.8.3 Lonza Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Lonza Therapeutic Peptide APIs Product Portfolio
6.8.5 Lonza Recent Developments/Updates
6.9 Aspen API
6.9.1 Aspen API Company Information
6.9.2 Aspen API Description and Business Overview
6.9.3 Aspen API Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Aspen API Therapeutic Peptide APIs Product Portfolio
6.9.5 Aspen API Recent Developments/Updates
6.10 Syngene
6.10.1 Syngene Company Information
6.10.2 Syngene Description and Business Overview
6.10.3 Syngene Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Syngene Therapeutic Peptide APIs Product Portfolio
6.10.5 Syngene Recent Developments/Updates
6.11 USV Peptides
6.11.1 USV Peptides Company Information
6.11.2 USV Peptides Description and Business Overview
6.11.3 USV Peptides Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 USV Peptides Therapeutic Peptide APIs Product Portfolio
6.11.5 USV Peptides Recent Developments/Updates
6.12 Bio Basic
6.12.1 Bio Basic Company Information
6.12.2 Bio Basic Description and Business Overview
6.12.3 Bio Basic Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Bio Basic Therapeutic Peptide APIs Product Portfolio
6.12.5 Bio Basic Recent Developments/Updates
6.13 JPT Peptide Technologies
6.13.1 JPT Peptide Technologies Company Information
6.13.2 JPT Peptide Technologies Description and Business Overview
6.13.3 JPT Peptide Technologies Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 JPT Peptide Technologies Therapeutic Peptide APIs Product Portfolio
6.13.5 JPT Peptide Technologies Recent Developments/Updates
6.14 ScinoPharm
6.14.1 ScinoPharm Company Information
6.14.2 ScinoPharm Description and Business Overview
6.14.3 ScinoPharm Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 ScinoPharm Therapeutic Peptide APIs Product Portfolio
6.14.5 ScinoPharm Recent Developments/Updates
6.15 Piramal Pharma
6.15.1 Piramal Pharma Company Information
6.15.2 Piramal Pharma Description and Business Overview
6.15.3 Piramal Pharma Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Piramal Pharma Therapeutic Peptide APIs Product Portfolio
6.15.5 Piramal Pharma Recent Developments/Updates
6.16 Jiangsu Sinopep-Allsino Biopharmaceutical
6.16.1 Jiangsu Sinopep-Allsino Biopharmaceutical Company Information
6.16.2 Jiangsu Sinopep-Allsino Biopharmaceutical Description and Business Overview
6.16.3 Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Product Portfolio
6.16.5 Jiangsu Sinopep-Allsino Biopharmaceutical Recent Developments/Updates
6.17 Cheng Du Sheng Nuo Biotec
6.17.1 Cheng Du Sheng Nuo Biotec Company Information
6.17.2 Cheng Du Sheng Nuo Biotec Description and Business Overview
6.17.3 Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Product Portfolio
6.17.5 Cheng Du Sheng Nuo Biotec Recent Developments/Updates
6.18 Hybio Pharmaceutical
6.18.1 Hybio Pharmaceutical Company Information
6.18.2 Hybio Pharmaceutical Description and Business Overview
6.18.3 Hybio Pharmaceutical Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Hybio Pharmaceutical Therapeutic Peptide APIs Product Portfolio
6.18.5 Hybio Pharmaceutical Recent Developments/Updates
6.19 Hainan Shuangcheng Pharmaceuticals
6.19.1 Hainan Shuangcheng Pharmaceuticals Company Information
6.19.2 Hainan Shuangcheng Pharmaceuticals Description and Business Overview
6.19.3 Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Product Portfolio
6.19.5 Hainan Shuangcheng Pharmaceuticals Recent Developments/Updates
6.20 Guangdong Jianyuan Pharmaceutical
6.20.1 Guangdong Jianyuan Pharmaceutical Company Information
6.20.2 Guangdong Jianyuan Pharmaceutical Description and Business Overview
6.20.3 Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Product Portfolio
6.20.5 Guangdong Jianyuan Pharmaceutical Recent Developments/Updates
6.21 Zhejiang Peptites Biotech
6.21.1 Zhejiang Peptites Biotech Company Information
6.21.2 Zhejiang Peptites Biotech Description and Business Overview
6.21.3 Zhejiang Peptites Biotech Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Zhejiang Peptites Biotech Therapeutic Peptide APIs Product Portfolio
6.21.5 Zhejiang Peptites Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Therapeutic Peptide APIs Industry Chain Analysis
7.2 Therapeutic Peptide APIs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Therapeutic Peptide APIs Production Mode & Process Analysis
7.4 Therapeutic Peptide APIs Sales and Marketing
7.4.1 Therapeutic Peptide APIs Sales Channels
7.4.2 Therapeutic Peptide APIs Distributors
7.5 Therapeutic Peptide APIs Customer Analysis
8 Therapeutic Peptide APIs Market Dynamics
8.1 Therapeutic Peptide APIs Industry Trends
8.2 Therapeutic Peptide APIs Market Drivers
8.3 Therapeutic Peptide APIs Market Challenges
8.4 Therapeutic Peptide APIs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Therapeutic Peptide APIs by Type
1.2.1 Global Therapeutic Peptide APIs Market Value by Type: 2025 vs 2032
1.2.2 Bioactive Peptides
1.2.3 Synthetic Peptides
1.3 Therapeutic Peptide APIs by Application
1.3.1 Global Therapeutic Peptide APIs Market Value by Application: 2025 vs 2032
1.3.2 Pharmaceuticals
1.3.3 Scientific Research
1.3.4 Other
1.4 Global Therapeutic Peptide APIs Market Size Estimates and Forecasts
1.4.1 Global Therapeutic Peptide APIs Revenue 2021–2032
1.4.2 Global Therapeutic Peptide APIs Sales 2021–2032
1.4.3 Global Therapeutic Peptide APIs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Therapeutic Peptide APIs Market Competition by Manufacturers
2.1 Global Therapeutic Peptide APIs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Therapeutic Peptide APIs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Therapeutic Peptide APIs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Therapeutic Peptide APIs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Therapeutic Peptide APIs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Therapeutic Peptide APIs, Product Types and Applications
2.7 Global Key Manufacturers of Therapeutic Peptide APIs, Date of Entry into the Industry
2.8 Global Therapeutic Peptide APIs Market Competitive Situation and Trends
2.8.1 Global Therapeutic Peptide APIs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Therapeutic Peptide APIs Players Market Share by Revenue
2.8.3 Global Therapeutic Peptide APIs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Therapeutic Peptide APIs Market Scenario by Region
3.1 Global Therapeutic Peptide APIs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Therapeutic Peptide APIs Sales by Region: 2021–2032
3.2.1 Global Therapeutic Peptide APIs Sales by Region: 2021–2026
3.2.2 Global Therapeutic Peptide APIs Sales by Region: 2027–2032
3.3 Global Therapeutic Peptide APIs Revenue by Region: 2021–2032
3.3.1 Global Therapeutic Peptide APIs Revenue by Region: 2021–2026
3.3.2 Global Therapeutic Peptide APIs Revenue by Region: 2027–2032
3.4 North America Therapeutic Peptide APIs Market Facts & Figures by Country
3.4.1 North America Therapeutic Peptide APIs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Therapeutic Peptide APIs Sales by Country (2021–2032)
3.4.3 North America Therapeutic Peptide APIs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Therapeutic Peptide APIs Market Facts & Figures by Country
3.5.1 Europe Therapeutic Peptide APIs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Therapeutic Peptide APIs Sales by Country (2021–2032)
3.5.3 Europe Therapeutic Peptide APIs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Therapeutic Peptide APIs Market Facts & Figures by Region
3.6.1 Asia Pacific Therapeutic Peptide APIs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Therapeutic Peptide APIs Sales by Region (2021–2032)
3.6.3 Asia Pacific Therapeutic Peptide APIs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Therapeutic Peptide APIs Market Facts & Figures by Country
3.7.1 Latin America Therapeutic Peptide APIs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Therapeutic Peptide APIs Sales by Country (2021–2032)
3.7.3 Latin America Therapeutic Peptide APIs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Therapeutic Peptide APIs Market Facts & Figures by Country
3.8.1 Middle East and Africa Therapeutic Peptide APIs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Therapeutic Peptide APIs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Therapeutic Peptide APIs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Therapeutic Peptide APIs Sales by Type (2021–2032)
4.1.1 Global Therapeutic Peptide APIs Sales by Type (2021–2026)
4.1.2 Global Therapeutic Peptide APIs Sales by Type (2027–2032)
4.1.3 Global Therapeutic Peptide APIs Sales Market Share by Type (2021–2032)
4.2 Global Therapeutic Peptide APIs Revenue by Type (2021–2032)
4.2.1 Global Therapeutic Peptide APIs Revenue by Type (2021–2026)
4.2.2 Global Therapeutic Peptide APIs Revenue by Type (2027–2032)
4.2.3 Global Therapeutic Peptide APIs Revenue Market Share by Type (2021–2032)
4.3 Global Therapeutic Peptide APIs Price by Type (2021–2032)
5 Segment by Application
5.1 Global Therapeutic Peptide APIs Sales by Application (2021–2032)
5.1.1 Global Therapeutic Peptide APIs Sales by Application (2021–2026)
5.1.2 Global Therapeutic Peptide APIs Sales by Application (2027–2032)
5.1.3 Global Therapeutic Peptide APIs Sales Market Share by Application (2021–2032)
5.2 Global Therapeutic Peptide APIs Revenue by Application (2021–2032)
5.2.1 Global Therapeutic Peptide APIs Revenue by Application (2021–2026)
5.2.2 Global Therapeutic Peptide APIs Revenue by Application (2027–2032)
5.2.3 Global Therapeutic Peptide APIs Revenue Market Share by Application (2021–2032)
5.3 Global Therapeutic Peptide APIs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Bachem
6.1.1 Bachem Company Information
6.1.2 Bachem Description and Business Overview
6.1.3 Bachem Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Bachem Therapeutic Peptide APIs Product Portfolio
6.1.5 Bachem Recent Developments/Updates
6.2 GenScript
6.2.1 GenScript Company Information
6.2.2 GenScript Description and Business Overview
6.2.3 GenScript Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 GenScript Therapeutic Peptide APIs Product Portfolio
6.2.5 GenScript Recent Developments/Updates
6.3 AmbioPharm
6.3.1 AmbioPharm Company Information
6.3.2 AmbioPharm Description and Business Overview
6.3.3 AmbioPharm Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 AmbioPharm Therapeutic Peptide APIs Product Portfolio
6.3.5 AmbioPharm Recent Developments/Updates
6.4 Limitless Biotech
6.4.1 Limitless Biotech Company Information
6.4.2 Limitless Biotech Description and Business Overview
6.4.3 Limitless Biotech Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Limitless Biotech Therapeutic Peptide APIs Product Portfolio
6.4.5 Limitless Biotech Recent Developments/Updates
6.5 CPC Scientific
6.5.1 CPC Scientific Company Information
6.5.2 CPC Scientific Description and Business Overview
6.5.3 CPC Scientific Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 CPC Scientific Therapeutic Peptide APIs Product Portfolio
6.5.5 CPC Scientific Recent Developments/Updates
6.6 PolyPeptide
6.6.1 PolyPeptide Company Information
6.6.2 PolyPeptide Description and Business Overview
6.6.3 PolyPeptide Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 PolyPeptide Therapeutic Peptide APIs Product Portfolio
6.6.5 PolyPeptide Recent Developments/Updates
6.7 CordenPharma
6.7.1 CordenPharma Company Information
6.7.2 CordenPharma Description and Business Overview
6.7.3 CordenPharma Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 CordenPharma Therapeutic Peptide APIs Product Portfolio
6.7.5 CordenPharma Recent Developments/Updates
6.8 Lonza
6.8.1 Lonza Company Information
6.8.2 Lonza Description and Business Overview
6.8.3 Lonza Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Lonza Therapeutic Peptide APIs Product Portfolio
6.8.5 Lonza Recent Developments/Updates
6.9 Aspen API
6.9.1 Aspen API Company Information
6.9.2 Aspen API Description and Business Overview
6.9.3 Aspen API Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Aspen API Therapeutic Peptide APIs Product Portfolio
6.9.5 Aspen API Recent Developments/Updates
6.10 Syngene
6.10.1 Syngene Company Information
6.10.2 Syngene Description and Business Overview
6.10.3 Syngene Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Syngene Therapeutic Peptide APIs Product Portfolio
6.10.5 Syngene Recent Developments/Updates
6.11 USV Peptides
6.11.1 USV Peptides Company Information
6.11.2 USV Peptides Description and Business Overview
6.11.3 USV Peptides Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 USV Peptides Therapeutic Peptide APIs Product Portfolio
6.11.5 USV Peptides Recent Developments/Updates
6.12 Bio Basic
6.12.1 Bio Basic Company Information
6.12.2 Bio Basic Description and Business Overview
6.12.3 Bio Basic Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Bio Basic Therapeutic Peptide APIs Product Portfolio
6.12.5 Bio Basic Recent Developments/Updates
6.13 JPT Peptide Technologies
6.13.1 JPT Peptide Technologies Company Information
6.13.2 JPT Peptide Technologies Description and Business Overview
6.13.3 JPT Peptide Technologies Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 JPT Peptide Technologies Therapeutic Peptide APIs Product Portfolio
6.13.5 JPT Peptide Technologies Recent Developments/Updates
6.14 ScinoPharm
6.14.1 ScinoPharm Company Information
6.14.2 ScinoPharm Description and Business Overview
6.14.3 ScinoPharm Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 ScinoPharm Therapeutic Peptide APIs Product Portfolio
6.14.5 ScinoPharm Recent Developments/Updates
6.15 Piramal Pharma
6.15.1 Piramal Pharma Company Information
6.15.2 Piramal Pharma Description and Business Overview
6.15.3 Piramal Pharma Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Piramal Pharma Therapeutic Peptide APIs Product Portfolio
6.15.5 Piramal Pharma Recent Developments/Updates
6.16 Jiangsu Sinopep-Allsino Biopharmaceutical
6.16.1 Jiangsu Sinopep-Allsino Biopharmaceutical Company Information
6.16.2 Jiangsu Sinopep-Allsino Biopharmaceutical Description and Business Overview
6.16.3 Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Product Portfolio
6.16.5 Jiangsu Sinopep-Allsino Biopharmaceutical Recent Developments/Updates
6.17 Cheng Du Sheng Nuo Biotec
6.17.1 Cheng Du Sheng Nuo Biotec Company Information
6.17.2 Cheng Du Sheng Nuo Biotec Description and Business Overview
6.17.3 Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Product Portfolio
6.17.5 Cheng Du Sheng Nuo Biotec Recent Developments/Updates
6.18 Hybio Pharmaceutical
6.18.1 Hybio Pharmaceutical Company Information
6.18.2 Hybio Pharmaceutical Description and Business Overview
6.18.3 Hybio Pharmaceutical Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Hybio Pharmaceutical Therapeutic Peptide APIs Product Portfolio
6.18.5 Hybio Pharmaceutical Recent Developments/Updates
6.19 Hainan Shuangcheng Pharmaceuticals
6.19.1 Hainan Shuangcheng Pharmaceuticals Company Information
6.19.2 Hainan Shuangcheng Pharmaceuticals Description and Business Overview
6.19.3 Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Product Portfolio
6.19.5 Hainan Shuangcheng Pharmaceuticals Recent Developments/Updates
6.20 Guangdong Jianyuan Pharmaceutical
6.20.1 Guangdong Jianyuan Pharmaceutical Company Information
6.20.2 Guangdong Jianyuan Pharmaceutical Description and Business Overview
6.20.3 Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Product Portfolio
6.20.5 Guangdong Jianyuan Pharmaceutical Recent Developments/Updates
6.21 Zhejiang Peptites Biotech
6.21.1 Zhejiang Peptites Biotech Company Information
6.21.2 Zhejiang Peptites Biotech Description and Business Overview
6.21.3 Zhejiang Peptites Biotech Therapeutic Peptide APIs Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Zhejiang Peptites Biotech Therapeutic Peptide APIs Product Portfolio
6.21.5 Zhejiang Peptites Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Therapeutic Peptide APIs Industry Chain Analysis
7.2 Therapeutic Peptide APIs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Therapeutic Peptide APIs Production Mode & Process Analysis
7.4 Therapeutic Peptide APIs Sales and Marketing
7.4.1 Therapeutic Peptide APIs Sales Channels
7.4.2 Therapeutic Peptide APIs Distributors
7.5 Therapeutic Peptide APIs Customer Analysis
8 Therapeutic Peptide APIs Market Dynamics
8.1 Therapeutic Peptide APIs Industry Trends
8.2 Therapeutic Peptide APIs Market Drivers
8.3 Therapeutic Peptide APIs Market Challenges
8.4 Therapeutic Peptide APIs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Therapeutic Peptide APIs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Therapeutic Peptide APIs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Therapeutic Peptide APIs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Therapeutic Peptide APIs Sales (Tons) of Key Manufacturers (2021–2026)
Table 5. Global Therapeutic Peptide APIs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Therapeutic Peptide APIs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Therapeutic Peptide APIs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Therapeutic Peptide APIs Average Price (US$/kg) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Therapeutic Peptide APIs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Therapeutic Peptide APIs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Therapeutic Peptide APIs, Product Types and Applications
Table 12. Global Key Manufacturers of Therapeutic Peptide APIs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Therapeutic Peptide APIs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Therapeutic Peptide APIs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Therapeutic Peptide APIs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Therapeutic Peptide APIs Sales by Region (Tons), 2021–2026
Table 18. Global Therapeutic Peptide APIs Sales Market Share by Region (2021–2026)
Table 19. Global Therapeutic Peptide APIs Sales by Region (Tons), 2027–2032
Table 20. Global Therapeutic Peptide APIs Sales Market Share by Region (2027–2032)
Table 21. Global Therapeutic Peptide APIs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Therapeutic Peptide APIs Revenue Market Share by Region (2021–2026)
Table 23. Global Therapeutic Peptide APIs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Therapeutic Peptide APIs Revenue Market Share by Region (2027–2032)
Table 25. North America Therapeutic Peptide APIs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Therapeutic Peptide APIs Sales by Country (Tons), 2021–2026
Table 27. North America Therapeutic Peptide APIs Sales by Country (Tons), 2027–2032
Table 28. North America Therapeutic Peptide APIs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Therapeutic Peptide APIs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Therapeutic Peptide APIs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Therapeutic Peptide APIs Sales by Country (Tons), 2021–2026
Table 32. Europe Therapeutic Peptide APIs Sales by Country (Tons), 2027–2032
Table 33. Europe Therapeutic Peptide APIs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Therapeutic Peptide APIs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Therapeutic Peptide APIs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Therapeutic Peptide APIs Sales by Region (Tons), 2021–2026
Table 37. Asia Pacific Therapeutic Peptide APIs Sales by Region (Tons), 2027–2032
Table 38. Asia Pacific Therapeutic Peptide APIs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Therapeutic Peptide APIs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Therapeutic Peptide APIs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Therapeutic Peptide APIs Sales by Country (Tons), 2021–2026
Table 42. Latin America Therapeutic Peptide APIs Sales by Country (Tons), 2027–2032
Table 43. Latin America Therapeutic Peptide APIs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Therapeutic Peptide APIs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Therapeutic Peptide APIs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Therapeutic Peptide APIs Sales by Country (Tons), 2021–2026
Table 47. Middle East and Africa Therapeutic Peptide APIs Sales by Country (Tons), 2027–2032
Table 48. Middle East and Africa Therapeutic Peptide APIs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Therapeutic Peptide APIs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Therapeutic Peptide APIs Sales (Tons) by Type (2021–2026)
Table 51. Global Therapeutic Peptide APIs Sales (Tons) by Type (2027–2032)
Table 52. Global Therapeutic Peptide APIs Sales Market Share by Type (2021–2026)
Table 53. Global Therapeutic Peptide APIs Sales Market Share by Type (2027–2032)
Table 54. Global Therapeutic Peptide APIs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Therapeutic Peptide APIs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Therapeutic Peptide APIs Revenue Market Share by Type (2021–2026)
Table 57. Global Therapeutic Peptide APIs Revenue Market Share by Type (2027–2032)
Table 58. Global Therapeutic Peptide APIs Price (US$/kg) by Type (2021–2026)
Table 59. Global Therapeutic Peptide APIs Price (US$/kg) by Type (2027–2032)
Table 60. Global Therapeutic Peptide APIs Sales (Tons) by Application (2021–2026)
Table 61. Global Therapeutic Peptide APIs Sales (Tons) by Application (2027–2032)
Table 62. Global Therapeutic Peptide APIs Sales Market Share by Application (2021–2026)
Table 63. Global Therapeutic Peptide APIs Sales Market Share by Application (2027–2032)
Table 64. Global Therapeutic Peptide APIs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Therapeutic Peptide APIs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Therapeutic Peptide APIs Revenue Market Share by Application (2021–2026)
Table 67. Global Therapeutic Peptide APIs Revenue Market Share by Application (2027–2032)
Table 68. Global Therapeutic Peptide APIs Price (US$/kg) by Application (2021–2026)
Table 69. Global Therapeutic Peptide APIs Price (US$/kg) by Application (2027–2032)
Table 70. Bachem Company Information
Table 71. Bachem Description and Business Overview
Table 72. Bachem Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 73. Bachem Therapeutic Peptide APIs Product
Table 74. Bachem Recent Developments/Updates
Table 75. GenScript Company Information
Table 76. GenScript Description and Business Overview
Table 77. GenScript Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 78. GenScript Therapeutic Peptide APIs Product
Table 79. GenScript Recent Developments/Updates
Table 80. AmbioPharm Company Information
Table 81. AmbioPharm Description and Business Overview
Table 82. AmbioPharm Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 83. AmbioPharm Therapeutic Peptide APIs Product
Table 84. AmbioPharm Recent Developments/Updates
Table 85. Limitless Biotech Company Information
Table 86. Limitless Biotech Description and Business Overview
Table 87. Limitless Biotech Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 88. Limitless Biotech Therapeutic Peptide APIs Product
Table 89. Limitless Biotech Recent Developments/Updates
Table 90. CPC Scientific Company Information
Table 91. CPC Scientific Description and Business Overview
Table 92. CPC Scientific Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 93. CPC Scientific Therapeutic Peptide APIs Product
Table 94. CPC Scientific Recent Developments/Updates
Table 95. PolyPeptide Company Information
Table 96. PolyPeptide Description and Business Overview
Table 97. PolyPeptide Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 98. PolyPeptide Therapeutic Peptide APIs Product
Table 99. PolyPeptide Recent Developments/Updates
Table 100. CordenPharma Company Information
Table 101. CordenPharma Description and Business Overview
Table 102. CordenPharma Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 103. CordenPharma Therapeutic Peptide APIs Product
Table 104. CordenPharma Recent Developments/Updates
Table 105. Lonza Company Information
Table 106. Lonza Description and Business Overview
Table 107. Lonza Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 108. Lonza Therapeutic Peptide APIs Product
Table 109. Lonza Recent Developments/Updates
Table 110. Aspen API Company Information
Table 111. Aspen API Description and Business Overview
Table 112. Aspen API Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 113. Aspen API Therapeutic Peptide APIs Product
Table 114. Aspen API Recent Developments/Updates
Table 115. Syngene Company Information
Table 116. Syngene Description and Business Overview
Table 117. Syngene Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 118. Syngene Therapeutic Peptide APIs Product
Table 119. Syngene Recent Developments/Updates
Table 120. USV Peptides Company Information
Table 121. USV Peptides Description and Business Overview
Table 122. USV Peptides Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 123. USV Peptides Therapeutic Peptide APIs Product
Table 124. USV Peptides Recent Developments/Updates
Table 125. Bio Basic Company Information
Table 126. Bio Basic Description and Business Overview
Table 127. Bio Basic Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 128. Bio Basic Therapeutic Peptide APIs Product
Table 129. Bio Basic Recent Developments/Updates
Table 130. JPT Peptide Technologies Company Information
Table 131. JPT Peptide Technologies Description and Business Overview
Table 132. JPT Peptide Technologies Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 133. JPT Peptide Technologies Therapeutic Peptide APIs Product
Table 134. JPT Peptide Technologies Recent Developments/Updates
Table 135. ScinoPharm Company Information
Table 136. ScinoPharm Description and Business Overview
Table 137. ScinoPharm Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 138. ScinoPharm Therapeutic Peptide APIs Product
Table 139. ScinoPharm Recent Developments/Updates
Table 140. Piramal Pharma Company Information
Table 141. Piramal Pharma Description and Business Overview
Table 142. Piramal Pharma Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 143. Piramal Pharma Therapeutic Peptide APIs Product
Table 144. Piramal Pharma Recent Developments/Updates
Table 145. Jiangsu Sinopep-Allsino Biopharmaceutical Company Information
Table 146. Jiangsu Sinopep-Allsino Biopharmaceutical Description and Business Overview
Table 147. Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 148. Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Product
Table 149. Jiangsu Sinopep-Allsino Biopharmaceutical Recent Developments/Updates
Table 150. Cheng Du Sheng Nuo Biotec Company Information
Table 151. Cheng Du Sheng Nuo Biotec Description and Business Overview
Table 152. Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 153. Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Product
Table 154. Cheng Du Sheng Nuo Biotec Recent Developments/Updates
Table 155. Hybio Pharmaceutical Company Information
Table 156. Hybio Pharmaceutical Description and Business Overview
Table 157. Hybio Pharmaceutical Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 158. Hybio Pharmaceutical Therapeutic Peptide APIs Product
Table 159. Hybio Pharmaceutical Recent Developments/Updates
Table 160. Hainan Shuangcheng Pharmaceuticals Company Information
Table 161. Hainan Shuangcheng Pharmaceuticals Description and Business Overview
Table 162. Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 163. Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Product
Table 164. Hainan Shuangcheng Pharmaceuticals Recent Developments/Updates
Table 165. Guangdong Jianyuan Pharmaceutical Company Information
Table 166. Guangdong Jianyuan Pharmaceutical Description and Business Overview
Table 167. Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 168. Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Product
Table 169. Guangdong Jianyuan Pharmaceutical Recent Developments/Updates
Table 170. Zhejiang Peptites Biotech Company Information
Table 171. Zhejiang Peptites Biotech Description and Business Overview
Table 172. Zhejiang Peptites Biotech Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 173. Zhejiang Peptites Biotech Therapeutic Peptide APIs Product
Table 174. Zhejiang Peptites Biotech Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Therapeutic Peptide APIs Distributors List
Table 178. Therapeutic Peptide APIs Customers List
Table 179. Therapeutic Peptide APIs Market Trends
Table 180. Therapeutic Peptide APIs Market Drivers
Table 181. Therapeutic Peptide APIs Market Challenges
Table 182. Therapeutic Peptide APIs Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
Table 186. Authors List of This Report
List of Figures
Figure 1. Product Picture of Therapeutic Peptide APIs
Figure 2. Global Therapeutic Peptide APIs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Therapeutic Peptide APIs Market Share by Type: 2025 & 2032
Figure 4. Bioactive Peptides Product Picture
Figure 5. Synthetic Peptides Product Picture
Figure 6. Global Therapeutic Peptide APIs Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Therapeutic Peptide APIs Market Share by Application: 2025 & 2032
Figure 8. Pharmaceuticals
Figure 9. Scientific Research
Figure 10. Other
Figure 11. Global Therapeutic Peptide APIs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Therapeutic Peptide APIs Market Size (US$ Million), 2021–2032
Figure 13. Global Therapeutic Peptide APIs Sales (Tons), 2021–2032
Figure 14. Global Therapeutic Peptide APIs Average Price (US$/kg), 2021–2032
Figure 15. Therapeutic Peptide APIs Report Years Considered
Figure 16. Therapeutic Peptide APIs Sales Share by Manufacturers in 2025
Figure 17. Global Therapeutic Peptide APIs Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Therapeutic Peptide APIs Players: Market Share by Revenue in Therapeutic Peptide APIs in 2025
Figure 19. Therapeutic Peptide APIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Therapeutic Peptide APIs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Therapeutic Peptide APIs Sales Market Share by Country (2021–2032)
Figure 22. North America Therapeutic Peptide APIs Revenue Market Share by Country (2021–2032)
Figure 23. United States Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Therapeutic Peptide APIs Sales Market Share by Country (2021–2032)
Figure 26. Europe Therapeutic Peptide APIs Revenue Market Share by Country (2021–2032)
Figure 27. Germany Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Therapeutic Peptide APIs Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Therapeutic Peptide APIs Revenue Market Share by Region (2021–2032)
Figure 34. China Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Therapeutic Peptide APIs Sales Market Share by Country (2021–2032)
Figure 42. Latin America Therapeutic Peptide APIs Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Therapeutic Peptide APIs Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Therapeutic Peptide APIs Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Therapeutic Peptide APIs by Type (2021–2032)
Figure 53. Global Revenue Market Share of Therapeutic Peptide APIs by Type (2021–2032)
Figure 54. Global Therapeutic Peptide APIs Price (US$/kg) by Type (2021–2032)
Figure 55. Global Sales Market Share of Therapeutic Peptide APIs by Application (2021–2032)
Figure 56. Global Revenue Market Share of Therapeutic Peptide APIs by Application (2021–2032)
Figure 57. Global Therapeutic Peptide APIs Price (US$/kg) by Application (2021–2032)
Figure 58. Therapeutic Peptide APIs Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Therapeutic Peptide APIs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Therapeutic Peptide APIs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Therapeutic Peptide APIs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Therapeutic Peptide APIs Sales (Tons) of Key Manufacturers (2021–2026)
Table 5. Global Therapeutic Peptide APIs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Therapeutic Peptide APIs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Therapeutic Peptide APIs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Therapeutic Peptide APIs Average Price (US$/kg) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Therapeutic Peptide APIs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Therapeutic Peptide APIs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Therapeutic Peptide APIs, Product Types and Applications
Table 12. Global Key Manufacturers of Therapeutic Peptide APIs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Therapeutic Peptide APIs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Therapeutic Peptide APIs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Therapeutic Peptide APIs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Therapeutic Peptide APIs Sales by Region (Tons), 2021–2026
Table 18. Global Therapeutic Peptide APIs Sales Market Share by Region (2021–2026)
Table 19. Global Therapeutic Peptide APIs Sales by Region (Tons), 2027–2032
Table 20. Global Therapeutic Peptide APIs Sales Market Share by Region (2027–2032)
Table 21. Global Therapeutic Peptide APIs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Therapeutic Peptide APIs Revenue Market Share by Region (2021–2026)
Table 23. Global Therapeutic Peptide APIs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Therapeutic Peptide APIs Revenue Market Share by Region (2027–2032)
Table 25. North America Therapeutic Peptide APIs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Therapeutic Peptide APIs Sales by Country (Tons), 2021–2026
Table 27. North America Therapeutic Peptide APIs Sales by Country (Tons), 2027–2032
Table 28. North America Therapeutic Peptide APIs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Therapeutic Peptide APIs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Therapeutic Peptide APIs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Therapeutic Peptide APIs Sales by Country (Tons), 2021–2026
Table 32. Europe Therapeutic Peptide APIs Sales by Country (Tons), 2027–2032
Table 33. Europe Therapeutic Peptide APIs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Therapeutic Peptide APIs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Therapeutic Peptide APIs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Therapeutic Peptide APIs Sales by Region (Tons), 2021–2026
Table 37. Asia Pacific Therapeutic Peptide APIs Sales by Region (Tons), 2027–2032
Table 38. Asia Pacific Therapeutic Peptide APIs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Therapeutic Peptide APIs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Therapeutic Peptide APIs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Therapeutic Peptide APIs Sales by Country (Tons), 2021–2026
Table 42. Latin America Therapeutic Peptide APIs Sales by Country (Tons), 2027–2032
Table 43. Latin America Therapeutic Peptide APIs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Therapeutic Peptide APIs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Therapeutic Peptide APIs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Therapeutic Peptide APIs Sales by Country (Tons), 2021–2026
Table 47. Middle East and Africa Therapeutic Peptide APIs Sales by Country (Tons), 2027–2032
Table 48. Middle East and Africa Therapeutic Peptide APIs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Therapeutic Peptide APIs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Therapeutic Peptide APIs Sales (Tons) by Type (2021–2026)
Table 51. Global Therapeutic Peptide APIs Sales (Tons) by Type (2027–2032)
Table 52. Global Therapeutic Peptide APIs Sales Market Share by Type (2021–2026)
Table 53. Global Therapeutic Peptide APIs Sales Market Share by Type (2027–2032)
Table 54. Global Therapeutic Peptide APIs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Therapeutic Peptide APIs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Therapeutic Peptide APIs Revenue Market Share by Type (2021–2026)
Table 57. Global Therapeutic Peptide APIs Revenue Market Share by Type (2027–2032)
Table 58. Global Therapeutic Peptide APIs Price (US$/kg) by Type (2021–2026)
Table 59. Global Therapeutic Peptide APIs Price (US$/kg) by Type (2027–2032)
Table 60. Global Therapeutic Peptide APIs Sales (Tons) by Application (2021–2026)
Table 61. Global Therapeutic Peptide APIs Sales (Tons) by Application (2027–2032)
Table 62. Global Therapeutic Peptide APIs Sales Market Share by Application (2021–2026)
Table 63. Global Therapeutic Peptide APIs Sales Market Share by Application (2027–2032)
Table 64. Global Therapeutic Peptide APIs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Therapeutic Peptide APIs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Therapeutic Peptide APIs Revenue Market Share by Application (2021–2026)
Table 67. Global Therapeutic Peptide APIs Revenue Market Share by Application (2027–2032)
Table 68. Global Therapeutic Peptide APIs Price (US$/kg) by Application (2021–2026)
Table 69. Global Therapeutic Peptide APIs Price (US$/kg) by Application (2027–2032)
Table 70. Bachem Company Information
Table 71. Bachem Description and Business Overview
Table 72. Bachem Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 73. Bachem Therapeutic Peptide APIs Product
Table 74. Bachem Recent Developments/Updates
Table 75. GenScript Company Information
Table 76. GenScript Description and Business Overview
Table 77. GenScript Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 78. GenScript Therapeutic Peptide APIs Product
Table 79. GenScript Recent Developments/Updates
Table 80. AmbioPharm Company Information
Table 81. AmbioPharm Description and Business Overview
Table 82. AmbioPharm Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 83. AmbioPharm Therapeutic Peptide APIs Product
Table 84. AmbioPharm Recent Developments/Updates
Table 85. Limitless Biotech Company Information
Table 86. Limitless Biotech Description and Business Overview
Table 87. Limitless Biotech Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 88. Limitless Biotech Therapeutic Peptide APIs Product
Table 89. Limitless Biotech Recent Developments/Updates
Table 90. CPC Scientific Company Information
Table 91. CPC Scientific Description and Business Overview
Table 92. CPC Scientific Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 93. CPC Scientific Therapeutic Peptide APIs Product
Table 94. CPC Scientific Recent Developments/Updates
Table 95. PolyPeptide Company Information
Table 96. PolyPeptide Description and Business Overview
Table 97. PolyPeptide Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 98. PolyPeptide Therapeutic Peptide APIs Product
Table 99. PolyPeptide Recent Developments/Updates
Table 100. CordenPharma Company Information
Table 101. CordenPharma Description and Business Overview
Table 102. CordenPharma Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 103. CordenPharma Therapeutic Peptide APIs Product
Table 104. CordenPharma Recent Developments/Updates
Table 105. Lonza Company Information
Table 106. Lonza Description and Business Overview
Table 107. Lonza Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 108. Lonza Therapeutic Peptide APIs Product
Table 109. Lonza Recent Developments/Updates
Table 110. Aspen API Company Information
Table 111. Aspen API Description and Business Overview
Table 112. Aspen API Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 113. Aspen API Therapeutic Peptide APIs Product
Table 114. Aspen API Recent Developments/Updates
Table 115. Syngene Company Information
Table 116. Syngene Description and Business Overview
Table 117. Syngene Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 118. Syngene Therapeutic Peptide APIs Product
Table 119. Syngene Recent Developments/Updates
Table 120. USV Peptides Company Information
Table 121. USV Peptides Description and Business Overview
Table 122. USV Peptides Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 123. USV Peptides Therapeutic Peptide APIs Product
Table 124. USV Peptides Recent Developments/Updates
Table 125. Bio Basic Company Information
Table 126. Bio Basic Description and Business Overview
Table 127. Bio Basic Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 128. Bio Basic Therapeutic Peptide APIs Product
Table 129. Bio Basic Recent Developments/Updates
Table 130. JPT Peptide Technologies Company Information
Table 131. JPT Peptide Technologies Description and Business Overview
Table 132. JPT Peptide Technologies Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 133. JPT Peptide Technologies Therapeutic Peptide APIs Product
Table 134. JPT Peptide Technologies Recent Developments/Updates
Table 135. ScinoPharm Company Information
Table 136. ScinoPharm Description and Business Overview
Table 137. ScinoPharm Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 138. ScinoPharm Therapeutic Peptide APIs Product
Table 139. ScinoPharm Recent Developments/Updates
Table 140. Piramal Pharma Company Information
Table 141. Piramal Pharma Description and Business Overview
Table 142. Piramal Pharma Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 143. Piramal Pharma Therapeutic Peptide APIs Product
Table 144. Piramal Pharma Recent Developments/Updates
Table 145. Jiangsu Sinopep-Allsino Biopharmaceutical Company Information
Table 146. Jiangsu Sinopep-Allsino Biopharmaceutical Description and Business Overview
Table 147. Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 148. Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Product
Table 149. Jiangsu Sinopep-Allsino Biopharmaceutical Recent Developments/Updates
Table 150. Cheng Du Sheng Nuo Biotec Company Information
Table 151. Cheng Du Sheng Nuo Biotec Description and Business Overview
Table 152. Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 153. Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Product
Table 154. Cheng Du Sheng Nuo Biotec Recent Developments/Updates
Table 155. Hybio Pharmaceutical Company Information
Table 156. Hybio Pharmaceutical Description and Business Overview
Table 157. Hybio Pharmaceutical Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 158. Hybio Pharmaceutical Therapeutic Peptide APIs Product
Table 159. Hybio Pharmaceutical Recent Developments/Updates
Table 160. Hainan Shuangcheng Pharmaceuticals Company Information
Table 161. Hainan Shuangcheng Pharmaceuticals Description and Business Overview
Table 162. Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 163. Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Product
Table 164. Hainan Shuangcheng Pharmaceuticals Recent Developments/Updates
Table 165. Guangdong Jianyuan Pharmaceutical Company Information
Table 166. Guangdong Jianyuan Pharmaceutical Description and Business Overview
Table 167. Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 168. Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Product
Table 169. Guangdong Jianyuan Pharmaceutical Recent Developments/Updates
Table 170. Zhejiang Peptites Biotech Company Information
Table 171. Zhejiang Peptites Biotech Description and Business Overview
Table 172. Zhejiang Peptites Biotech Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 173. Zhejiang Peptites Biotech Therapeutic Peptide APIs Product
Table 174. Zhejiang Peptites Biotech Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Therapeutic Peptide APIs Distributors List
Table 178. Therapeutic Peptide APIs Customers List
Table 179. Therapeutic Peptide APIs Market Trends
Table 180. Therapeutic Peptide APIs Market Drivers
Table 181. Therapeutic Peptide APIs Market Challenges
Table 182. Therapeutic Peptide APIs Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
Table 186. Authors List of This Report
List of Figures
Figure 1. Product Picture of Therapeutic Peptide APIs
Figure 2. Global Therapeutic Peptide APIs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Therapeutic Peptide APIs Market Share by Type: 2025 & 2032
Figure 4. Bioactive Peptides Product Picture
Figure 5. Synthetic Peptides Product Picture
Figure 6. Global Therapeutic Peptide APIs Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Therapeutic Peptide APIs Market Share by Application: 2025 & 2032
Figure 8. Pharmaceuticals
Figure 9. Scientific Research
Figure 10. Other
Figure 11. Global Therapeutic Peptide APIs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Therapeutic Peptide APIs Market Size (US$ Million), 2021–2032
Figure 13. Global Therapeutic Peptide APIs Sales (Tons), 2021–2032
Figure 14. Global Therapeutic Peptide APIs Average Price (US$/kg), 2021–2032
Figure 15. Therapeutic Peptide APIs Report Years Considered
Figure 16. Therapeutic Peptide APIs Sales Share by Manufacturers in 2025
Figure 17. Global Therapeutic Peptide APIs Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Therapeutic Peptide APIs Players: Market Share by Revenue in Therapeutic Peptide APIs in 2025
Figure 19. Therapeutic Peptide APIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Therapeutic Peptide APIs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Therapeutic Peptide APIs Sales Market Share by Country (2021–2032)
Figure 22. North America Therapeutic Peptide APIs Revenue Market Share by Country (2021–2032)
Figure 23. United States Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Therapeutic Peptide APIs Sales Market Share by Country (2021–2032)
Figure 26. Europe Therapeutic Peptide APIs Revenue Market Share by Country (2021–2032)
Figure 27. Germany Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Therapeutic Peptide APIs Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Therapeutic Peptide APIs Revenue Market Share by Region (2021–2032)
Figure 34. China Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Therapeutic Peptide APIs Sales Market Share by Country (2021–2032)
Figure 42. Latin America Therapeutic Peptide APIs Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Therapeutic Peptide APIs Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Therapeutic Peptide APIs Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Therapeutic Peptide APIs by Type (2021–2032)
Figure 53. Global Revenue Market Share of Therapeutic Peptide APIs by Type (2021–2032)
Figure 54. Global Therapeutic Peptide APIs Price (US$/kg) by Type (2021–2032)
Figure 55. Global Sales Market Share of Therapeutic Peptide APIs by Application (2021–2032)
Figure 56. Global Revenue Market Share of Therapeutic Peptide APIs by Application (2021–2032)
Figure 57. Global Therapeutic Peptide APIs Price (US$/kg) by Application (2021–2032)
Figure 58. Therapeutic Peptide APIs Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232